A new strategy for the management of atherosclerotic plaque as a source of major adverse cardiac events is needed with the focus shifting from the flow-limiting coronary artery luminal lesions to the ...

Photo Credit: Adapted from: Ambrose JA. TCT-54: The distribution of hgh-risk plaques with respect to artery stenosis in non-culprit non-ischemic native coronary lesions of diabetic patients: data from ...

(UPDATED) Patients with vulnerable plaques identified with intravascular ultrasound and near-infrared spectroscopy (NIRS) are at a significantly increased risk of major adverse cardiovascular events, ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque volume, according to a study published online ...

Shown are the phases of rupture and healing of an atherosclerotic plaque. The cross-section of a plaque in Panel A shows a central core containing lipids and necrotic debris (yellow) and macrophage ...

ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea.

In a recent article published in the journal JAMA Cardiology, a team of European researchers investigated whether therapies aimed at lowering the levels of low-density lipoprotein cholesterol (LDL-C) ...

Psoriasis is a chronic inflammatory immune-cell mediated disease, mediated by cross talk between epidermal keratinocytes, dermal vascular cells, and immunocytes. Psoriatic plaques are well defined and ...